Teva Pharmaceutical Industries Ltd (TEVA) reports a 9% revenue increase, driven by innovative and generics business, despite ...
Littelfuse Inc (LFUS) reports robust cash flow and strategic design wins despite revenue declines and impairment charges in ...
( MENAFN - GlobeNewsWire - Nasdaq) Oslo, January 31, 2025: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, announces ...